Atlas Trials

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Clinical trial NCT00742417 · COMPLETED

Trial details

NCT number
NCT00742417
Sponsor
Instituto Grifols, S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2007-07-01
Primary completion
2011-02-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.